Anixa Biosciences (ANIX) Competitors

Anixa Biosciences (NASDAQ:ANIX) and Tectonic Therapeutic (NASDAQ:TECX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Which has more risk & volatility, ANIX or TECX?

Anixa Biosciences has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Comparatively, Tectonic Therapeutic has a beta of 3.27, meaning that its share price is 227% more volatile than the S&P 500.

Do insiders & institutionals believe in ANIX or TECX?

29.1% of Anixa Biosciences shares are owned by institutional investors. Comparatively, 62.6% of Tectonic Therapeutic shares are owned by institutional investors. 25.3% of Anixa Biosciences shares are owned by insiders. Comparatively, 38.0% of Tectonic Therapeutic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Is ANIX or TECX more profitable?

Tectonic Therapeutic's return on equity of -30.13% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anixa Biosciences	N/A	-68.17%	-60.38%
Tectonic Therapeutic	N/A	-30.13%	-28.33%

Which has preferable earnings & valuation, ANIX or TECX?

Anixa Biosciences has higher revenue and earnings than Tectonic Therapeutic. Anixa Biosciences is trading at a lower price-to-earnings ratio than Tectonic Therapeutic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anixa Biosciences	$210K	455.54	-$12.55M	-$0.38	-7.82
Tectonic Therapeutic	N/A	N/A	-$57.98M	-$4.04	-6.06

Do analysts recommend ANIX or TECX?

Anixa Biosciences presently has a consensus price target of $9.00, indicating a potential upside of 203.03%. Tectonic Therapeutic has a consensus price target of $80.33, indicating a potential upside of 228.29%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, analysts plainly believe Tectonic Therapeutic is more favorable than Anixa Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tectonic Therapeutic	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17

Does the media prefer ANIX or TECX?

In the previous week, Tectonic Therapeutic had 1 more articles in the media than Anixa Biosciences. MarketBeat recorded 4 mentions for Tectonic Therapeutic and 3 mentions for Anixa Biosciences. Anixa Biosciences' average media sentiment score of 0.38 beat Tectonic Therapeutic's score of 0.29 indicating that Anixa Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anixa Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tectonic Therapeutic	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Tectonic Therapeutic beats Anixa Biosciences on 11 of the 15 factors compared between the two stocks.